Ståhlberg D
Department of Medicine, Karolinska Institutet at Huddinge University Hospital, Stockholm, Sweden.
Lipids. 1995 Apr;30(4):361-4. doi: 10.1007/BF02536046.
The effects of pregnenolone-16 alpha-carbonitrile (PCN) on hepatic metabolism of cholesterol were studied in rat liver microsomes in order to clarify the underlying mechanisms of the PCN-induced biliary hypersecretion of cholesterol. Male Sprague-Dawley rats were fed a diet supplemented with 0.05% of PCN for one week. The microsomal activity of 3-hydroxy-3-methylglutaryl coenzyme A reductase, regulating cholesterol biosynthesis, decreased from 577 +/- 46 (SEM) to 367 +/- 38 pmol/min/mg protein compared to the controls. Cholesterol 7 alpha-hydroxylase activity, governing bile acid synthesis, was 9.0 +/- 1.1 pmol/min/mg protein in the treated group and 34.8 +/- 7.4 pmol/min/mg protein in the controls, a reduction of 74% (P < 0.01). The acyl CoA:cholesterol acyltransferase (ACAT) activity, catalyzing the esterification of cholesterol, remained unchanged, as did the levels of total and free cholesterol in liver homogenates and microsomes. The results of this study provide evidence that the increase in biliary cholesterol secretion during PCN treatment is not caused by a change in ACAT activity, but can be explained by a decreased catabolism of cholesterol to bile acids.
为了阐明孕烯醇酮 -16α- 腈(PCN)诱导胆汁中胆固醇分泌过多的潜在机制,研究了其对大鼠肝微粒体中胆固醇肝代谢的影响。雄性斯普拉格 - 道利大鼠喂食添加了0.05% PCN的饲料一周。与对照组相比,调节胆固醇生物合成的3-羟基-3-甲基戊二酰辅酶A还原酶的微粒体活性从577±46(标准误)降至367±38 pmol/分钟/毫克蛋白。处理组中控制胆汁酸合成的胆固醇7α-羟化酶活性为9.0±1.1 pmol/分钟/毫克蛋白,对照组为34.8±7.4 pmol/分钟/毫克蛋白,降低了74%(P<0.01)。催化胆固醇酯化的酰基辅酶A:胆固醇酰基转移酶(ACAT)活性保持不变,肝匀浆和微粒体中总胆固醇和游离胆固醇水平也保持不变。本研究结果表明,PCN治疗期间胆汁中胆固醇分泌增加不是由ACAT活性变化引起的,而是可以用胆固醇向胆汁酸的分解代谢减少来解释。